Showing results (1251-1260 of 2,691) with videos related to

Sort By:
Pageof 270
The Lancet. Infectious Diseases|July 14, 2024
Safety and immunogenicity of the intranasal H3N2 M2-deficient single-replication influenza vaccine alone or coadministered with an inactivated influenza vaccine (Fluzone High-Dose Quadrivalent) in adults aged 65-85 years in the USA: a multicentre, randomised, double-blind, double-dummy, phase 1b trialJoseph Eiden, Carlos Fierro, Alexander White, et al.
The Lancet. Infectious Diseases|August 16, 2024
Trends in infection incidence and antimicrobial resistance in the US Veterans Affairs Healthcare System: a nationwide retrospective cohort study (2007-22)Thi Mui Pham, Yue Zhang, McKenna Nevers, et al.
The Lancet. Infectious Diseases|August 16, 2024
Investigating the effect of enhanced cleaning and disinfection of shared medical equipment on health-care-associated infections in Australia (CLEEN): a stepped-wedge, cluster randomised, controlled trialKatrina Browne, Nicole M White, Philip L Russo, et al.
The Lancet. Infectious Diseases|May 9, 2024
Genotypic analysis of RTS,S/AS01E malaria vaccine efficacy against parasite infection as a function of dosage regimen and baseline malaria infection status in children aged 5-17 months in Ghana and Kenya: a longitudinal phase 2b randomised controlled trialMichal Juraska, Angela M Early, Li Li, et al.
The Lancet. Infectious Diseases|April 13, 2024
Immunogenicity and safety of an ORF7-deficient skin-attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2a trialHong-Xing Pan, Ling-Xian Qiu, Qi Liang, et al.
The Lancet. Infectious Diseases|April 25, 2024
The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in ChinaWenting Zuo, Di He, Chaoyang Liang, et al.
The Lancet. Infectious Diseases|January 25, 2026
Safety and efficacy of CRS3123 in adults with a primary episode or first recurrence of Clostridioides difficile infection: a phase 2, randomised, double-blind, multicentre, vancomycin-controlled studyThomas Louie, Wendy Ribble, Louis Boccumini, et al.
The Lancet. Infectious Diseases|January 15, 2026
Impact of universal nirsevimab prophylaxis in infants on hospital and primary care outcomes across two respiratory syncytial virus seasons in Galicia, Spain (NIRSE-GAL): a population-based prospective observational studyJosefina L Razzini, Iago Giné-Vázquez, Jing Jin, et al.
The Lancet. Infectious Diseases|November 28, 2025
Empirical and targeted antimicrobial therapy in patients with febrile neutropenia and haematological malignancy or after haematopoietic cell transplantation: recommendations from the 10th European Conference on Infections in LeukaemiaDina Averbuch, Yuri Vanbiervliet, Francesco Baccelli, et al.
The Lancet. Infectious Diseases|December 1, 2025
Effectiveness of the maternal RSVpreF vaccine against severe disease in infants in Scotland, UK: a national, population-based case-control study and cohort analysisIsobel McLachlan, Chris Robertson, Kirsty E Morrison, et al.
Pageof 270